Yesterday, Dec. 21, 2015, 57 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $3.18 to $70,037,432.50.

Highlighted Stocks Traded by Insiders:

Jason Industries (JASN) - FREE Research Report

Scopus Partners, L.P., who is 10% Owner at Jason Industries, sold 548 shares at $3.18 on Dec. 21, 2015. Following this transaction, the 10% Owner owned 99,098 shares meaning that the stake was reduced by 0.55% with the 548-share transaction.

Scopus Vista Partners, L.P., who is 10% Owner at Jason Industries, sold 1 shares at $3.18 on Dec. 21, 2015. Following this transaction, the 10% Owner owned 87,818 shares meaning that the stake was reduced by 0% with the 1-share transaction.

Scopus Fund Ltd., who is 10% Owner at Jason Industries, sold 2,184 shares at $3.18 on Dec. 21, 2015. Following this transaction, the 10% Owner owned 376,858 shares meaning that the stake was reduced by 0.58% with the 2,184-share transaction.

Scopus Vista Fund Ltd., who is 10% Owner at Jason Industries, sold 1 shares at $3.18 on Dec. 21, 2015. Following this transaction, the 10% Owner owned 26,244 shares meaning that the stake was reduced by 0% with the 1-share transaction.

Scopus Partners Ii, L.P., who is 10% Owner at Jason Industries, sold 3,004 shares at $3.18 on Dec. 21, 2015. Following this transaction, the 10% Owner owned 409,982 shares meaning that the stake was reduced by 0.73% with the 3,004-share transaction.

The shares most recently traded at $3.57, up $0.39, or 10.92% since the insider transaction. Historical insider transactions for Jason Industries go as follows:

  • 4-Week # shares bought: 38,674
  • 4-Week # shares sold: 150,926
  • 12-Week # shares bought: 82,150
  • 12-Week # shares sold: 221,062
  • 24-Week # shares bought: 226,508
  • 24-Week # shares sold: 221,062

The average volume for Jason Industries has been 35,600 shares per day over the past 30 days. Jason Industries has a market cap of $81.4 million and is part of the industrial goods sector and industrial industry. Shares are down 62.74% year-to-date as of the close of trading on Monday.

Jason Industries, Inc., together with its subsidiaries, engages in the manufacture of seating, finishing, acoustics, and components in the United States and internationally. Currently, there are 2 analysts who rate Jason Industries a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on JASN - FREE

TheStreet Quant Ratings

rates Jason Industries as a

sell

. The company's weaknesses can be seen in multiple areas, such as its generally disappointing historical performance in the stock itself, generally high debt management risk and poor profit margins. Get the full

Jason Industries Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Xencor (XNCR) - FREE Research Report

Kuch John J, who is Vice President, Finance at Xencor, sold 4,781 shares at $14.89 on Dec. 21, 2015. Following this transaction, the Vice President, Finance owned 10,650 shares meaning that the stake was reduced by 30.98% with the 4,781-share transaction.

The shares most recently traded at $14.54, down $0.35, or 2.38% since the insider transaction. Historical insider transactions for Xencor go as follows:

  • 4-Week # shares sold: 30,000
  • 12-Week # shares sold: 30,000
  • 24-Week # shares sold: 50,000

The average volume for Xencor has been 327,900 shares per day over the past 30 days. Xencor has a market cap of $609.6 million and is part of the health care sector and drugs industry. Shares are down 10.29% year-to-date as of the close of trading on Monday.

Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on discovery and development of engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs. Currently, there are 3 analysts who rate Xencor a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on XNCR - FREE

TheStreet Quant Ratings

rates Xencor as a

sell

. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income and generally disappointing historical performance in the stock itself. Get the full

Xencor Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Delta Air Lines (DAL) - FREE Research Report

Blake Francis S, who is Director at Delta Air Lines, bought 4,915 shares at $50.83 on Dec. 21, 2015. Following this transaction, the Director owned 18,065 shares meaning that the stake was boosted by 37.38% with the 4,915-share transaction.

The shares most recently traded at $51.81, up $0.98, or 1.89% since the insider transaction. Historical insider transactions for Delta Air Lines go as follows:

  • 4-Week # shares bought: 5,000
  • 4-Week # shares sold: 2,480
  • 12-Week # shares bought: 5,000
  • 12-Week # shares sold: 62,980
  • 24-Week # shares bought: 5,000
  • 24-Week # shares sold: 216,980

The average volume for Delta Air Lines has been 9.1 million shares per day over the past 30 days. Delta Air Lines has a market cap of $39.3 billion and is part of the services sector and transportation industry. Shares are up 4.61% year-to-date as of the close of trading on Monday.

Delta Air Lines, Inc. provides scheduled air transportation for passengers and cargo worldwide. The company operates in two segments, Airline and Refinery. Its route network comprises various gateway airports in Amsterdam, Detroit, Los Angeles, Minneapolis-St. The stock currently has a dividend yield of 1.08%. The company has a P/E ratio of 14.1. Currently, there are 10 analysts who rate Delta Air Lines a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on DAL - FREE

TheStreet Quant Ratings

rates Delta Air Lines as a

buy

. The company's strengths can be seen in multiple areas, such as its increase in net income, solid stock price performance, growth in earnings per share, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full

Delta Air Lines Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.